GLP-1 therapy is not right for everyone, and these medications work best as part of a comprehensive plan that includes nutrition, movement, and personalized clinical guidance
Nong Y, Wu G, Lu J, Wei X, Yu D
These findings emphasize the necessity for continuous, long-term monitoring of patients receiving combination therapy with GLP-1 receptor agonists and metformin, regardless of treatment duration, to ensure timely identification and management of potential adverse events
BMC Complementary and Alternative Medicine, 18 (1), 26
Armed with this information, your PlexusDx provider can personalize your medication choice, dose escalation timeline, and lifestyle interventions, turning a one-size-fits-all approach into a precision protocol tailored to your biology